Long-term effects of tripeptide Ile-Pro-Pro on osteoblast differentiation in vitro

Journal of Nutritional Biochemistry

Volumn 19, Issue 10, 2008, Pages 708-715

  Huttunen, Minna M ^a   Pekkinen, Minna ^a   Ahlström, Mikael E B ^a   Lamberg Allardt, Christel J E ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bioactive peptide; hMSC; IPP; Osteoblast differentiation

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BETA CATENIN; CASPASE 8; ISOLEUCYLPROLYLPROLINE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; TRANSCRIPTION FACTOR RUNX2; TRIPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BONE MATRIX; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESENCHYMAL STEM CELL; MINERALIZATION; OSSIFICATION; OSTEOBLAST; POLYMERASE CHAIN REACTION;

ALKALINE PHOSPHATASE; BASE SEQUENCE; BONE AND BONES; CELL DIFFERENTIATION; CELLS, CULTURED; DNA PRIMERS; HUMANS; MINERALS; OLIGOPEPTIDES; OSTEOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 50949133597     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.09.006     Document Type: Article

References (47)

1. Ryoo H.M., Hoffmann H.M., Beumer T., Frenkel B., Towler D.A., Stein G.S., et al. Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol 11 11 (1997) 1681-1694
2. Hannan M.T., Tucker K.L., Dawson-Huges B., Cupples L.A., Felson D.T., and Kiel D.P. Effect of dietary protein on bone loss in elderly men and women: The Framingham Osteoporosis study. J Bone Miner Res 15 (2000) 2504-2512
3. Hoppe C., Molgaard C., and Michaelsen K.F. Bone size and bone mass in 10-year-old Danish children: effect of current diet. Osteoporos Int 11 12 (2000) 1024-1030
4. Kerstetter J.E., O'Brien K.O., and Insogna K.L. Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr 133 (2003) 855S-861S
5. Whiting S.J., Boyle J.L., Thompson A., Mirwald R.L., and Faulkner R.A. Dietary protein, phosphorus, and potassium are beneficial to bone mineral density in adult men consuming adequate dietary calcium. J Am Coll Nutr 21 5 (2002) 402-409
6. Bowen J., Noakes M., and Clifton P.M. A high dairy protein, high-calcium diet minimizes bone turnover in overweight adults during weight loss. J Nutr 134 (2004) 568-573
7. Wengreen H.J., Munger R.G., West N.A., Cutler D.R., Corcoran C.D., Zhang J., et al. Dietary protein intake and risk of osteoporotic hip fracture in elderly residents of Utah. J Bone Miner Res 19 (2004) 537-545
8. Alexy U., Remer T., Manz F., Neu C.M., and Schoenau E. Long-term protein intake and dietary potential renal acid load are associated with bone modeling and remodeling at the proximal radius in healthy children. Am J Clin Nutr 82 (2005) 1107-1114
9. Thissen J.P., Ketelslegers J.M., and Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocr Rev 15 (1994) 80-101
10. Ginty F. Dietary protein and bone health. Proc Nutr Soc 62 4 (2003) 867-876
11. Meisel H., and Bockelmann W. Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie Van Leeuwenhoek 76 (1999) 207-215
12. Huttunen MM, Pekkinen M, Ahlström M, Lamberg-Allardt CJE. The effects of IPP, VPP and LKP on human osteoblast gene expression. Br J Nutr 2007;98:780--8.
13. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
14. Bodine P.V., Trailsmith M., and Komm B.S. Development and characterization of a conditionally transformed adult human osteoblastic cell line. J Bone Miner Res 11 (1996) 806-819
15. Ahlström M., Pekkinen M., Huttunen M., and Lamberg-Allardt C. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells. Biochem Pharmacol 69 (2004) 267-275
16. Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143 3 (1990) 420-430
17. Beloti M.M., and Rosa A.L. Osteoblast differentiation of human bone marrow cells under continuous and discontinuous treatment with dexamethasone. Braz Dent J 16 (2005) 156-161
18. Beck Jr. G.R., Zerler B., and Moran E. Gene array analysis of osteoblast differentiation. Cell Growth Differ 12 2 (2001) 61-83
19. Cheng S.-L., Zhang S.-F., and Avioli L.V. Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cells. J Cell Biochem 61 (1996) 182-193
20. Liu F., Malaval L., and Aubin J.E. Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation. J Cell Sci 116 (2003) 1787-1796
21. Osyczka A.M., and Leboy P.S. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146 (2005) 3428-3437
22. Dworetzky S.I., Fey E.G., Penman S., Lian J.B., Stein J.L., and Stein G.S. Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc Natl Acad Sci U S A 87 (1990) 4605-4609
23. Moore M.A.S. Converging pathways in leukemogenesis and stem cell self-renewal. Exp Hematol 33 (2005) 719-737
24. Krishnan V., Bryant H.U., and MacDougald O.A. Regulation of bone mass by Wnt signaling. J Clin Invest 116 (2006) 1202-1209
25. Qi H., Aguiar D.J., Williams S.M., Pean A L.A., Pan W., and Verfaille C.M. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci U S A 100 (2003) 3305-3310
26. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
27. Kahler R.A., and Westendorf J.J. Lymphoid enhancer factor-1 and β-catenin inhibit Runx2-dependent transcriptional activation of the osteoclacin promoter. J Biol Chem 278 (2003) 11937-11944
28. Gaur T., Lengner C.J., Hovhannisyan H., Bhat R.A., Bodine P.V., Komm B.S., et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280 (2005) 33132-33140
29. Shui C., Spelsberg T.C., Riggs B.L., and Khosla S. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 18 (2003) 213-221
30. Spencer G.J., Utting J.C., Etheridge S.L., Arnett T.R., and Genever P.G. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro. J Cell Sci 119 (2006) 1283-1296
31. Glass D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., et al. Canonical Wnt signalling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8 (2005) 751-764
32. Narva M., Halleen J., Väänänen K., and Korpela R. Effects of Lactobacillus helveticus fermented milk on bone cells in vitro. Life Sci 75 (2004) 1727-1734
33. Balint E., Lapointe D., Drissi H., van der Meijden C., Young D.W., van Wijnen A.J., et al. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J Cell Biochem 89 (2003) 401-426
34. Hamajima S., Hiratsuka K., Kiyama-Kishikawa M., Tagawa T., Kawahara M., Ohta M., et al. Effect of low-level laser irradiation on osteoglycin gene expression in osteoblasts. Lasers Med Sci 18 (2003) 78-82
35. Almeida M., Han L., Bellido T., Manolagas S.C., and Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280 (2005) 41342-41351
36. Jilka R.L., Weinstein R.S., Bellido T., Parfitt A.M., and Manolagas S.C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13 (1998) 793-802
37. Martin T.J. Osteoblast-derived PTHrP is a physiological regulator of bone formation. J Clin Invest 115 (2005) 2324-2333
38. Karaplis A.C., and Goltzman D. PTH and PTHrP effects on the skeleton. Rev Endocr Metab Disord 1 (2000) 331-341
39. Swarthout J.T., D'Alonzo R.C., Selvamurugan N., and Partridge N. Parathyroid hormone-dependent signalling pathways regulating genes in bone cells. Gene 282 (2002) 1-17
40. Kulkarni N.H., Halladay D.L., Miles R.R., Gilbert L.M., Frolik C.A., Gavin R.J.S., et al. Effects of parathyroid hormone on Wnt signalling pathway in bone. J Cell Biochem 95 (2005) 1178-1190
41. Chavassieux P.M., Chenu C., Valentin-Opran A., Marle B., Delmas P.D., Hartmann D.J., et al. Influence of experimental conditions on osteoblast activity in human primary bone cell cultures. J Bone Miner Res 5 (1990) 337-343
42. Wordinger R.J., Agarwal R., Talati M., Fuller J., Lambert W., and Clark A.F. Express of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis 8 (2002) 241-250
43. Wang J., Krill D., Torbenson M., Wang Q., Bisceglia M., Stoner J., et al. Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens. Urol Res 28 (2000) 308-315
44. Gomes A.C., Jönsson G., Mjörnheim S., Olsson T., Hillert J., and Grandien A. Upregulation of the apoptosis regulators cFLIP, CD95, and CD95 ligand in peripheral blood mononuclear cells in relapsing-remitting multiple sclerosis. J Neuroimmunol 135 (2003) 126-134
45. Kusumi A., Sakaki H., Kusumi T., Oda M., Narita K., Nakagawa H., et al. Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain. J Bone Miner Metab 23 (2005) 373-381
46. Kuliwaba J.S., Findlay D.M., Atkins G.J., Forwood M.R., and Fazzalari N.L. Enhanced expression of osteocalcin mRNA in human osteoarthritic trabecular bone of the proximal femur is associated with decreased expression of interleukin-6 and interleukin-11 mRNA. J Bone Miner Res 15 (2000) 332-341
47. Richard V., Luchin A., Brena R.M., Plass C., and Rosol T.J. Quantitative evaluation of alternative promoter usage and 3′ splice variants for parathyroid hormone-related protein by real-time reverse transcription-PCR. Clin Chem 49 (2003) 1398-1402